Faeth Therapeutics (FTH) revenue and earnings history
Faeth Therapeutics's annual figures for 6 fiscal years, as filed with the SEC.
Revenue and net income, 6 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | — | −$22.3M | −$21.1M | −$20.5M | $16K | −$20.5M | $1.27M | — | — | $8.67M | — | 10-K |
| 2024ended Dec 31, 2024 | — |
The latest quarter, insider trades and fund moves: Faeth Therapeutics (FTH) on OQRO.
Common questions
Has Faeth Therapeutics been profitable?
It reported a net loss in 6 of the years shown (2020, 2021, 2022, 2023, 2024, 2025). The highest net income was −$20.1M in fiscal 2020.
What was Faeth Therapeutics's free cash flow in fiscal 2025?
−$20.5M: operating cash flow of −$20.5M minus capital expenditure of $16K. OQRO calculates free cash flow this way from the two filed lines.
How much cash has Faeth Therapeutics returned to shareholders?
Its cash-flow statements show $10.4M on buying back its own shares over 1 fiscal year ($0 in fiscal 2025). These are the dollar amounts paid in each year, as filed; a year with no figure means none was tagged.
Where these figures come from
The SEC’s companyfacts data: every figure Faeth Therapeutics tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.